Cart
sales@molnova.com
Ganolucidic acid D
CAS No. 102607-22-7
Ganolucidic acid D( —— )
Catalog No. M32449 CAS No. 102607-22-7
Ganolucidic acid D, also known as ganolucidate D, is a triterpenoid.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 351 | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGanolucidic acid D
-
NoteResearch use only, not for human use.
-
Brief DescriptionGanolucidic acid D, also known as ganolucidate D, is a triterpenoid.
-
DescriptionGanolucidic acid D, also known as ganolucidate D, is a triterpenoid.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number102607-22-7
-
Formula Weight500.7
-
Molecular FormulaC30H44O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Tenilsetam
Tenilsetam is an endonuclease modulator; a nootropic agent and advanced glycation end product (AGE) inhibitor having potential for Alzheimer's disease (AD) treatment.
-
Siplizumab
Siplizumab (MEDI-507) is a humanized IgG1 monoclonal antibody that targets CD2, selectively depleting effector memory T cells and promoting the relative expansion of alloreactive regulatory T cells in vitro. Siplizumab can be used to treat plaque psoriasis.
-
Cytidine 5'-diphosph...
Cytidine 5'-diphosphate disodium produces CTP to support DNA and RNA biosynthesis and ribonucleotide reductase to produce dCMP.
